{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T19:56:00Z","timestamp":1776801360013,"version":"3.51.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T00:00:00Z","timestamp":1602892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T00:00:00Z","timestamp":1602892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41372-020-00861-2","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T07:03:23Z","timestamp":1602918203000},"page":"865-872","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["\u201cFenofibrate as an adjuvant to phototherapy in pathological unconjugated hyperbilirubinemia in neonates: a randomized control trial.\u201d"],"prefix":"10.1038","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9177-6554","authenticated-orcid":false,"given":"Mohammad Hosny","family":"Awad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9033-6290","authenticated-orcid":false,"given":"Islam","family":"Nour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4477-3297","authenticated-orcid":false,"given":"AbdElaziz","family":"Shabaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,17]]},"reference":[{"key":"861_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1089\/bfm.2015.0170","volume":"11","author":"WM Waite","year":"2016","unstructured":"Waite WM, Taylor JA. Phototherapy for the treatment of neonatal jaundice and breastfeeding duration and exclusivity. Breastfeed Med. 2016;11:180\u20135.","journal-title":"Breastfeed Med"},{"key":"861_CR2","doi-asserted-by":"publisher","first-page":"e20171471","DOI":"10.1542\/peds.2017-1471","volume":"141","author":"BO Olusanya","year":"2018","unstructured":"Olusanya BO, Teeple S, Kassebaum NJ. The contribution of neonatal jaundice to global child mortality: findings from the GBD 2016 Study. Pediatrics. 2018;141:e20171471.","journal-title":"Pediatrics"},{"key":"861_CR3","doi-asserted-by":"publisher","first-page":"e0197113","DOI":"10.1371\/journal.pone.0197113","volume":"13","author":"L Zhang","year":"2018","unstructured":"Zhang L. Severe neonatal hyperbilirubinemia induces temporal and occipital lobe seizures. PLoS ONE. 2018;13:e0197113.","journal-title":"PLoS ONE"},{"key":"861_CR4","doi-asserted-by":"publisher","first-page":"e886","DOI":"10.1542\/peds.2012-0253","volume":"130","author":"M Sgro","year":"2012","unstructured":"Sgro M, Campbell DM, Kandasamy S, Shah V. Incidence of chronic bilirubin encephalopathy in Canada, 2007-8. Pediatrics. 2012;130:e886\u201390.","journal-title":"Pediatrics"},{"key":"861_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4103\/2249-4847.154111","volume":"4","author":"H Al-Asy","year":"2015","unstructured":"Al-Asy H, El-Sharkawy H, Mabrouk M, Hamad M. Effect of fenofibrate on indirect neonatal hyperbilirubinemia. J Clin Neonatol. 2015;4:82.","journal-title":"J Clin Neonatol"},{"key":"861_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/apa.14141","volume":"107","author":"K Mreihil","year":"2018","unstructured":"Mreihil K, Benth J\u0160, Stensvold HJ, Nakstad B, Hansen TWR, Scheck O, et al. Phototherapy is commonly used for neonatal jaundice but greater control is needed to avoid toxicity in the most vulnerable infants. Acta Paediatr Int J Paediatr. 2018;107:611\u20139.","journal-title":"Acta Paediatr Int J Paediatr"},{"key":"861_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1542\/peds.114.1.297","volume":"114","author":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia.","year":"2004","unstructured":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297\u2013316.","journal-title":"Pediatrics"},{"key":"861_CR8","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.arcped.2014.02.005","volume":"21","author":"A Cortey","year":"2014","unstructured":"Cortey A, Elzaabi M, Waegemans T, Roch B, Aujard Y. Efficacit\u00e9 et tol\u00e9rance des immunoglobulines polyvalentes dans l\u2019hyperbilirubin\u00e9mie n\u00e9onatale par incompatibilit\u00e9 ABO. M\u00e9ta-analyse. Arch Pediatr. 2014;21:976\u201383.","journal-title":"Arch Pediatr"},{"key":"861_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/17474086.2017.1331124","volume":"10","author":"IMC Ree","year":"2017","unstructured":"Ree IMC, Smits-Wintjens VEHJ, van der Bom JG, van Klink JMM, Oepkes D, Lopriore E. Neonatal management and outcome in alloimmune hemolytic disease. Expert Rev Hematol. 2017;10:607\u201316.","journal-title":"Expert Rev Hematol."},{"key":"861_CR10","first-page":"93","volume":"41","author":"A B\u00fclb\u00fcl","year":"2011","unstructured":"B\u00fclb\u00fcl A, Okan FF, Kabako\u01e7lu \u00dcns\u00fcr E, Nuho\u01e7lu A. Adverse events associated with exchange transfusion and etiology of severe hyperbilirubinemia in near-term and term newborns. Turkish J Med Sci. 2011;41:93\u2013100.","journal-title":"Turkish J Med Sci"},{"key":"861_CR11","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/cmdc.201900128","volume":"14","author":"L Giampietro","year":"2019","unstructured":"Giampietro L, Ammazzalorso A, Amoroso R, De, Filippis B. Development of fibrates as important scaffolds in medicinal chemistry. ChemMedChem. 2019;14:1051\u201366.","journal-title":"ChemMedChem."},{"key":"861_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-230X-7-44","volume":"7","author":"M Cindoruk","year":"2007","unstructured":"Cindoruk M, Kerem M, Karakan T, Salman B, Akin O, Alper M, et al. Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study. BMC Gastroenterol. 2007;7:44.","journal-title":"BMC Gastroenterol"},{"key":"861_CR13","first-page":"CD009017","volume":"12","author":"M Gholitabar","year":"2012","unstructured":"Gholitabar M, McGuire H, Rennie J, Manning D, Lai R. Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia. Cochrane Database Syst Rev. 2012;12:CD009017.","journal-title":"Cochrane Database Syst Rev"},{"key":"861_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.32677\/IJCH.2016.v03.i01.012","volume":"03","author":"GS Chaudhary","year":"2016","unstructured":"Chaudhary GS, Chaudhary V, Chaurasiya OS, Chandrakant V, Kumar V. Oral fenofibrate in neonatal hyperbilirubinemia: a randomized controlled trial. Indian J Child Health. 2016;03:54\u20138.","journal-title":"Indian J Child Health"},{"key":"861_CR15","first-page":"69","volume":"11","author":"AC Goldberg","year":"1989","unstructured":"Goldberg AC, Schonfeld G, Feldman EB, Ginsberg HN, Hunninghake DB, Insull W, et al. Fenofibrate for the treatment of type IV and V hyperlipoproteinemias: a double-blind placebo-controlled multicenter US study. Clin Ther. 1989;11:69\u201383.","journal-title":"Clin Ther"},{"key":"861_CR16","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1161\/01.ATV.6.6.670","volume":"6","author":"WV Brown","year":"1986","unstructured":"Brown WV, Dujovne CA, Farquhar JW, Feldman EB, Grundy SM, Knopp RH, et al. Effects of fenofibrate on plasma lipids. Double-blind, multicenter study in patients with Type IIA or IIB hyperlipidemia. Arteriosclerosis. 1986;6:670\u20138.","journal-title":"Arteriosclerosis"},{"key":"861_CR17","first-page":"5","volume":"5","author":"B Kumar","year":"2012","unstructured":"Kumar B, Agarwal P, Chorishi A, Dhaneria M. Fenofibrate: a novel approach in treating uncomplicated neonatal hyperbilirubinemia? People\u2019s J Sci Res. 2012;5:5\u20138.","journal-title":"People\u2019s J Sci Res"},{"key":"861_CR18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/clinchem\/29.3.538","volume":"29","author":"MW McGowan","year":"1983","unstructured":"McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem. 1983;29:538\u201342.","journal-title":"Clin Chem"},{"key":"861_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5223\/pghn.2017.20.1.1","volume":"20","author":"J Zeevenhooven","year":"2017","unstructured":"Zeevenhooven J, Koppen IJN, Benninga MA. The new Rome IV criteria for functional gastrointestinal disorders in infants and toddlers. Pediatr Gastroenterol Hepatol Nutr. 2017;20:1\u201313.","journal-title":"Pediatr Gastroenterol Hepatol Nutr."},{"key":"861_CR20","first-page":"16","volume":"11","author":"A Wan","year":"2016","unstructured":"Wan A, Mat Daud S, Teh SH, Choo YM, Kutty FM. Management of neonatal jaundice in primary care. Malays Fam physician J Acad Fam Physicians Malays. 2016;11:16\u20139.","journal-title":"Malays Fam physician J Acad Fam Physicians Malays"},{"key":"861_CR21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/ped.13332","volume":"59","author":"S Itoh","year":"2017","unstructured":"Itoh S, Okada H, Kuboi T, Kusaka T. Phototherapy for neonatal hyperbilirubinemia. Pediatr Int. 2017;59:959\u201366.","journal-title":"Pediatr Int."},{"key":"861_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4632-2","volume":"12","author":"DN Magai","year":"2019","unstructured":"Magai DN, Mwaniki M, Abubakar A, Mohammed S, Gordon AL, Kalu R, et al. A randomized control trial of phototherapy and 20% albumin versus phototherapy and saline in Kilifi, Kenya. BMC Res Notes. 2019;12:617.","journal-title":"BMC Res Notes"},{"key":"861_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.eplepsyres.2016.05.004","volume":"124","author":"RD Maimburg","year":"2016","unstructured":"Maimburg RD, Olsen J, Sun Y. Neonatal hyperbilirubinemia and the risk of febrile seizures and childhood epilepsy. Epilepsy Res. 2016;124:67\u201372.","journal-title":"Epilepsy Res"},{"key":"861_CR24","doi-asserted-by":"publisher","first-page":"e20151354","DOI":"10.1542\/peds.2015-1354","volume":"137","author":"TB Newman","year":"2016","unstructured":"Newman TB, Wickremasinghe AC, Walsh EM, Grimes BA, McCulloch CE, Kuzniewicz MW. Retrospective cohort study of phototherapy and childhood cancer in Northern California. Pediatrics. 2016;137:e20151354\u2013e20151354.","journal-title":"Pediatrics"},{"key":"861_CR25","first-page":"75","volume":"12","author":"M Hamidi","year":"2013","unstructured":"Hamidi M, Zamanzad B, Mesripour A. Comparing the effect of clofibrate and phenobarbital on the newborns with hyperbilirubinemia. EXCLI J. 2013;12:75\u20138.","journal-title":"EXCLI J"},{"key":"861_CR26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12098-011-0531-9","volume":"79","author":"R Fallah","year":"2012","unstructured":"Fallah R, Islami Z, Lotfi SR. Single dose of 50 mg\/kg clofibrate in jaundice of healthy term neonates: randomised clinical trial of efficacy and safety. Indian J Pediatr. 2012;79:194\u20137.","journal-title":"Indian J Pediatr"},{"key":"861_CR27","first-page":"48","volume":"20","author":"R Sharafi","year":"2010","unstructured":"Sharafi R, Mortazavi Z, Sharafi S, Parashkouh RM. The effect of clofibrate on decreasing serum bilirubin in healthy term neonates under home phototherapy. Iran J Pediatr. 2010;20:48\u201352.","journal-title":"Iran J Pediatr"},{"key":"861_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4103\/0019-5359.53162","volume":"63","author":"SH Sakha","year":"2009","unstructured":"Sakha SH, Gharehbaghi M, Rahbani M. The effect of clofibrate with phototherapy in late pre-term newborns with non-hemolytic jaundice. Indian J Med Sci. 2009;63:174\u20139.","journal-title":"Indian J Med Sci"},{"key":"861_CR29","first-page":"21","volume":"50","author":"M Habibi","year":"2012","unstructured":"Habibi M, Mahyar A, Ayazi P, Ahmadabadi F, Javadi A. The effect of clofibrate on hyperbilirubinemia of term neonates. Acta Med Iran. 2012;50:21\u20135.","journal-title":"Acta Med Iran"},{"key":"861_CR30","first-page":"8317","volume":"6","author":"M Ahmadpour-kacho","year":"2018","unstructured":"Ahmadpour-kacho M, Zahed Pasha Y, Moghadamnia AA, Khafri S, Vafaeinezhad M. The effect of oral fenofibrate on serum bilirubin level in term neonates with hyperbilirubinemia: a randomized clinical trail. Int J Pediatr. 2018;6:8317\u201327.","journal-title":"Int J Pediatr"},{"key":"861_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.21608\/anj.2020.69366","volume":"2","author":"S Al-Banna","year":"2019","unstructured":"Al-Banna S, Riad A, Anes S. The effect of fenofibrate and antioxidant vitamins [D, E and C] in treatment of uncomplicated neonatal hyperbilirubinemia. Ann Neonatol J. 2019;2:37\u201348.","journal-title":"Ann Neonatol J"},{"key":"861_CR32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4103\/2249-4847.191248","volume":"5","author":"M El-Frargy","year":"2016","unstructured":"El-Frargy M, El-Sharkawy H, Attia G. Therapeutic difference in some treatment modalities of jaundice in Egyptian neonates. J Clin Neonatol. 2016;5:162.","journal-title":"J Clin Neonatol"},{"key":"861_CR33","first-page":"253","volume":"13","author":"BL Anantha Narayana Gowda","year":"2014","unstructured":"Anantha Narayana Gowda BL, Professor A, Karnataka D. Efficacy of oral fenofibrate in the management of unconjugated hyperbilirubinemia in neonates prospective study. Sci Technol. 2014;13:253.","journal-title":"Sci Technol"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41372-020-00861-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-020-00861-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-020-00861-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T01:08:51Z","timestamp":1634432931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-020-00861-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,17]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1038\/s41372-020-00861-2","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,17]]},"assertion":[{"value":"5 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}